These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 37211256)
1. Impact of HMGB1 binding on the structural alterations of platinum drug-treated single dsDNA molecule. Mondal S; Banerjee S; Dey D; Lahiri H; Mana T; Jana SS; Mukhopadhyay R Biochimie; 2023 Oct; 213():168-175. PubMed ID: 37211256 [TBL] [Abstract][Full Text] [Related]
2. DNA compaction by mononuclear platinum cancer drug cisplatin and the trisplatinum anticancer agent BBR3464: Differences and similarities. Banerjee T; Dubey P; Mukhopadhyay R Biochimie; 2012 Feb; 94(2):494-502. PubMed ID: 21893159 [TBL] [Abstract][Full Text] [Related]
3. Understanding the Interactions of High-Mobility Group of Protein Domain B1 with DNA Adducts Generated by Platinum Anticancer Molecules Using In Silico Approaches. Misra G; Gupta S; Jabalia N Interdiscip Sci; 2018 Sep; 10(3):476-485. PubMed ID: 27900730 [TBL] [Abstract][Full Text] [Related]
4. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent. Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899 [TBL] [Abstract][Full Text] [Related]
5. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA. Park S; Lippard SJ Biochemistry; 2011 Apr; 50(13):2567-74. PubMed ID: 21355578 [TBL] [Abstract][Full Text] [Related]
6. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes. Novakova O; Kasparkova J; Malina J; Natile G; Brabec V Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903 [TBL] [Abstract][Full Text] [Related]
7. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand. Kasparkova J; Vojtiskova M; Natile G; Brabec V Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972 [TBL] [Abstract][Full Text] [Related]
8. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex. Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702 [TBL] [Abstract][Full Text] [Related]
9. Compacting effect of BBR3464, a new-generation trisplatinum anticancer agent, on DNA. Banerjee T; Dubey P; Mukhopadhyay R Biochimie; 2010 Jul; 92(7):846-51. PubMed ID: 20138107 [TBL] [Abstract][Full Text] [Related]
10. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464. Zehnulova J; Kasparkova J; Farrell N; Brabec V J Biol Chem; 2001 Jun; 276(25):22191-9. PubMed ID: 11303029 [TBL] [Abstract][Full Text] [Related]
11. Structural changes of DNA induced by mono- and binuclear cancer drugs. Mukhopadhyay R; Dubey P; Sarkar S J Struct Biol; 2005 Jun; 150(3):277-83. PubMed ID: 15890276 [TBL] [Abstract][Full Text] [Related]
12. The Application of ATR-FTIR Spectroscopy and the Reversible DNA Conformation as a Sensor to Test the Effectiveness of Platinum(II) Anticancer Drugs. Al-Jorani K; Rüther A; Martin M; Haputhanthri R; Deacon GB; Li HL; Wood BR Sensors (Basel); 2018 Dec; 18(12):. PubMed ID: 30563229 [TBL] [Abstract][Full Text] [Related]
13. Effect of in vivo post-translational modifications of the HMGB1 protein upon binding to platinated DNA: a molecular simulation study. Lv WL; Arnesano F; Carloni P; Natile G; Rossetti G Nucleic Acids Res; 2018 Dec; 46(22):11687-11697. PubMed ID: 30407547 [TBL] [Abstract][Full Text] [Related]
14. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure. Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952 [TBL] [Abstract][Full Text] [Related]
15. Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins. Wei M; Cohen SM; Silverman AP; Lippard SJ J Biol Chem; 2001 Oct; 276(42):38774-80. PubMed ID: 11514569 [TBL] [Abstract][Full Text] [Related]
16. Computational metallomics of the anticancer drug cisplatin. Calandrini V; Rossetti G; Arnesano F; Natile G; Carloni P J Inorg Biochem; 2015 Dec; 153():231-238. PubMed ID: 26490711 [TBL] [Abstract][Full Text] [Related]
17. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA. Malina J; Natile G; Brabec V Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652 [TBL] [Abstract][Full Text] [Related]
18. Redox-sensitive structural change in the A-domain of HMGB1 and its implication for the binding to cisplatin modified DNA. Wang J; Tochio N; Takeuchi A; Uewaki J; Kobayashi N; Tate S Biochem Biophys Res Commun; 2013 Nov; 441(4):701-6. PubMed ID: 24427810 [TBL] [Abstract][Full Text] [Related]
19. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts. Kasparkova J; Novakova O; Farrell N; Brabec V Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292 [TBL] [Abstract][Full Text] [Related]
20. Structural changes of linear DNA molecules induced by cisplatin. Liu Z; Liu R; Zhou Z; Zu Y; Xu F Biochem Biophys Res Commun; 2015 Feb; 457(4):688-92. PubMed ID: 25619135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]